Hélène Burckel

1.4k total citations · 1 hit paper
26 papers, 1.1k citations indexed

About

Hélène Burckel is a scholar working on Oncology, Cancer Research and Genetics. According to data from OpenAlex, Hélène Burckel has authored 26 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Cancer Research and 7 papers in Genetics. Recurrent topics in Hélène Burckel's work include Glioma Diagnosis and Treatment (7 papers), PARP inhibition in cancer therapy (6 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Hélène Burckel is often cited by papers focused on Glioma Diagnosis and Treatment (7 papers), PARP inhibition in cancer therapy (6 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Hélène Burckel collaborates with scholars based in France, United Kingdom and United States. Hélène Burckel's co-authors include G. Noël, Elodie Josset, D. Antoni, Waïsse Waïssi, François Chevalier, Paul Lesueur, Yannick Saintigny, Jean‐Louis Habrand, Florence Joly and Gertraud Orend and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Hélène Burckel

24 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Three-Dimensional Cell Culture: A Breakthrough in Vivo

2015 723 citations D. Antoni, Hélène Burckel et al. International Journal of Molecular Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hélène Burckel France	10	464	369	319	134	121	26	1.1k
Caleb Jensen United States	5	639 1.4×	362 1.0×	309 1.0×	75 0.6×	131 1.1×	5	1.2k
Amanda Jiang United States	18	505 1.1×	385 1.0×	192 0.6×	254 1.9×	148 1.2×	24	1.2k
Matthew Ibbs Poland	6	586 1.3×	376 1.0×	370 1.2×	79 0.6×	92 0.8×	11	1.2k
Weronika Przybyła Poland	6	583 1.3×	418 1.1×	368 1.2×	85 0.6×	98 0.8×	8	1.2k
Łukasz Łuczewski Poland	10	586 1.3×	475 1.3×	439 1.4×	113 0.8×	183 1.5×	21	1.5k
Marta Kapałczyńska Poland	6	594 1.3×	449 1.2×	469 1.5×	120 0.9×	214 1.8×	8	1.4k
Susan Breslin Ireland	8	823 1.8×	537 1.5×	551 1.7×	98 0.7×	103 0.9×	10	1.5k
Chu Zhang China	19	209 0.5×	397 1.1×	233 0.7×	152 1.1×	138 1.1×	76	1.1k
Seishi Kono Japan	9	388 0.8×	384 1.0×	397 1.2×	55 0.4×	78 0.6×	15	940
Steven D. Forsythe United States	18	764 1.6×	271 0.7×	579 1.8×	87 0.6×	273 2.3×	34	1.3k

Countries citing papers authored by Hélène Burckel

Since Specialization

Citations

This map shows the geographic impact of Hélène Burckel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hélène Burckel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hélène Burckel more than expected).

Fields of papers citing papers by Hélène Burckel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hélène Burckel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hélène Burckel. The network helps show where Hélène Burckel may publish in the future.

Co-authorship network of co-authors of Hélène Burckel

This figure shows the co-authorship network connecting the top 25 collaborators of Hélène Burckel. A scholar is included among the top collaborators of Hélène Burckel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hélène Burckel. Hélène Burckel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Burckel, Hélène, Carole Mura, Corentin Richard, et al.. (2025). Distinct immune responses to proton and photon radiotherapy: implications for anti-PD-L1 combination therapy in colorectal cancer. Journal of Translational Medicine. 23(1). 360–360.

Entz‐Werlé, Natacha, et al.. (2024). Overcoming the limits of pediatric brain tumor radiotherapy: The use of preclinical 3D models. Cancer/Radiothérapie. 28(5). 424–434. 3 indexed citations

Noël, G., et al.. (2024). Tumor reirradiation: Issues, challenges and perspectives for radiobiology. Cancer/Radiothérapie. 28(5). 493–502. 3 indexed citations

Noël, G., et al.. (2024). Preclinical and clinical advances to overcome hypoxia in glioblastoma multiforme. Cell Death and Disease. 15(7). 503–503. 17 indexed citations

Noël, G., et al.. (2024). The neglected burden of chronic hypoxia on the resistance of glioblastoma multiforme to first-line therapies. BMC Biology. 22(1). 278–278. 5 indexed citations

Mathieu, C., Carole Mura, Anna M. Grabowska, et al.. (2023). Clinically Translatable Transcrocetin Delivery Platform for Correction of Tumor Hypoxia and Enhancement of Radiation Therapy Effects. Small. 19(12). e2205961–e2205961. 3 indexed citations

Seitlinger, Joseph, Julien Demiselle, Ysia Idoux‐Gillet, et al.. (2023). Patient-Derived Tumoroid for the Prediction of Radiotherapy and Chemotherapy Responses in Non-Small-Cell Lung Cancer. Biomedicines. 11(7). 1824–1824. 2 indexed citations

Cébula, H., Julien Garnon, Julien Todeschi, et al.. (2021). Interventional magnetic-resonance-guided cryotherapy combined with microsurgery for recurrent glioblastoma: An innovative treatment?. Neurochirurgie. 68(3). 267–272.

Waïssi, Waïsse, Jean‐Christophe Amé, Carole Mura, G. Noël, & Hélène Burckel. (2021). Gemcitabine-Based Chemoradiotherapy Enhanced by a PARP Inhibitor in Pancreatic Cancer Cell Lines. International Journal of Molecular Sciences. 22(13). 6825–6825. 14 indexed citations

10.

Foppolo, Sophie, Véronique Bruban, Nelly Étienne-Selloum, et al.. (2021). Cav1/EREG/YAP Axis in the Treatment Resistance of Cav1-Expressing Head and Neck Squamous Cell Carcinoma. Cancers. 13(12). 3038–3038. 9 indexed citations

11.

Spenlé, Caroline, Thomas Loustau, Hélène Burckel, et al.. (2021). Impact of Tenascin-C on Radiotherapy in a Novel Syngeneic Oral Squamous Cell Carcinoma Model With Spontaneous Dissemination to the Lymph Nodes. Frontiers in Immunology. 12. 636108–636108. 8 indexed citations

12.

Mirjolet, Céline, Emeric Limagne, Carole Mura, et al.. (2021). Impact of proton therapy on antitumor immune response. Scientific Reports. 11(1). 13444–13444. 35 indexed citations

13.

Brasse, David, Hélène Burckel, Patrice Marchand, et al.. (2021). Comparison of the [18F]-FDG and [18F]-FLT PET Tracers in the Evaluation of the Preclinical Proton Therapy Response in Hepatocellular Carcinoma. Molecular Imaging and Biology. 23(5). 724–732. 1 indexed citations

14.

Cébula, H., G. Noël, Julien Garnon, et al.. (2020). The Cryo-immunologic effect: A therapeutic advance in the treatment of glioblastomas?. Neurochirurgie. 66(6). 455–460. 6 indexed citations

15.

Waïssi, Waïsse, et al.. (2020). Targeting DNA repair in combination with radiotherapy in pancreatic cancer: A systematic review of preclinical studies. Critical Reviews in Oncology/Hematology. 153. 103060–103060. 6 indexed citations

16.

Spenlé, Caroline, Falk Saupe, Kim S. Midwood, et al.. (2015). Tenascin-C: Exploitation and collateral damage in cancer management. Cell Adhesion & Migration. 9(1-2). 141–153. 53 indexed citations

17.

Antoni, D., Hélène Burckel, Elodie Josset, & G. Noël. (2015). Three-Dimensional Cell Culture: A Breakthrough in Vivo. International Journal of Molecular Sciences. 16(3). 5517–5527. 723 indexed citations breakdown →

18.

Antoni, D., Hélène Burckel, Elodie Josset, G. Noël, & F. Mornex. (2014). Radiobiologie des doses ablatives en radiothérapie stéréotaxique : mise au point des données récentes. Cancer/Radiothérapie. 18(4). 264–269. 5 indexed citations

19.

Burckel, Hélène, Elodie Josset, Jean‐Marc Denis, et al.. (2014). Combination of the mTOR inhibitor RAD001 with temozolomide and radiation effectively inhibits the growth of glioblastoma cells in culture. Oncology Reports. 33(1). 471–477. 6 indexed citations

20.

Josset, Elodie, Hélène Burckel, G. Noël, & Pierre Bischoff. (2013). The mTOR inhibitor RAD001 potentiates autophagic cell death induced by temozolomide in a glioblastoma cell line.. PubMed. 33(5). 1845–51. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact